Medical device briefs
Thursday, 05 February, 2009
Nanosonics has been granted approval by the Therapeutic Goods Administration to market its Trophon EPR device.
The device disinfects ultrasound probes and is aimed at hospitals, specialists and radiology clinics.
It has received earlier approval in the EU, Canada and New Zealand and is awaiting approval from the US FDA.
Polartechnics has signed agreements in Thailand, the Philippines, Indonesia and Sri Lanka for its TruScreen and CerviScreen diagnostics.
TruScreen is a point-of-care test for HPV while CerviScreen is a self-administered test.
Listed lab consumables company Fluorotechnics has changed its trading name to Gel Company. Its ASX name will remain the same.
AI-designed DNA switches flip genes on and off
The work creates the opportunity to turn the expression of a gene up or down in just one tissue...
Drug delays tumour growth in models of children's liver cancer
A new drug has been shown to delay the growth of tumours and improve survival in hepatoblastoma,...
Ancient DNA rewrites the stories of those preserved at Pompeii
Researchers have used ancient DNA to challenge long-held assumptions about the inhabitants of...
